The European Regulatory Landscape for Pediatric Drug Development

Barry Mangum

In my 35 years of working to develop safer, more effective medications for children, I’ve often been asked about how to navigate the regulatory landscape in the US and Europe. In a previous blog post, I discussed the latest FDA trends regarding pediatric drug development. In this blog, I’ll focus on the path for achieving […]

Read More
Topics: Clinical Pharmacology Strategy, PK/PD Modeling & Simulation
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog